{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:50:38Z","timestamp":1790985038017,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.nbd.2008.05.008","type":"journal-article","created":{"date-parts":[[2008,5,31]],"date-time":"2008-05-31T04:17:32Z","timestamp":1212207452000},"page":"334-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Amiloride is neuroprotective in an MPTP model of Parkinson's disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Robert L.","family":"Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Li A.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Vasylyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Albinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Kubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Zaleska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Bowlby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.05.008_bib1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.2006.04102.x","article-title":"Parkinsonism genes: culprits and clues","volume":"99","author":"Abeliovich","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.05.008_bib2","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1523\/JNEUROSCI.23-34-10982.2003","article-title":"Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively","volume":"34","author":"Alfinito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.05.008_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson's disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2008.05.008_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.nbd.2008.05.008_bib6","first-page":"61","article-title":"Proton MR spectroscopy of the brain in 14 patients with Parkinson disease","volume":"16","author":"Bowen","year":"1995","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2008.05.008_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2008.05.008_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-199304000-00011","article-title":"NMDA antagonists partially protect against MPTP induced neurotoxicity in mice","volume":"4","author":"Brouillet","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2008.05.008_bib9","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.05.008_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1110\/ps.0307003","article-title":"Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels","volume":"12","author":"Escoubas","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.nbd.2008.05.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2008.05.008_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum","volume":"89","author":"Ferger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.05.008_bib58","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2008"},{"key":"10.1016\/j.nbd.2008.05.008_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/nm1668","article-title":"Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system","volume":"13","author":"Friese","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2008.05.008_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-2952(90)90323-D","article-title":"Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain","volume":"40","author":"Garritsen","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2008.05.008_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1089\/0897715041269722","article-title":"Extracellular brain pH and outcome following severe traumatic brain injury","volume":"21","author":"Gupta","year":"2004","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2008.05.008_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/ajrcmb.26.1.4657","article-title":"Amiloride blockades lipopolysaccharides-induced proinflammatory cytokine biosynthesis in an I\u03baB-\u03b1\/NF-\u03baB-dependent mechanism: evidence for the amplification of an anti-inflammatory pathway in the alveolar epithelium","volume":"26","author":"Haddad","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.nbd.2008.05.008_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0955-0674(98)80056-2","article-title":"Amiloride-sensitive Na+ channels","volume":"10","author":"Horisberger","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.nbd.2008.05.008_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nn0901-869","article-title":"Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons","volume":"4","author":"Immke","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/jcbfm.1988.73","article-title":"Pathogenesis of substantia nigra lesions following hyperglycemic ischemia: changes in energy metabolites, cerebral blood flow, and morphology of pars reticulata in a rat model of ischemia","volume":"8","author":"Inamura","year":"1988","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2008.05.008_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"3","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.05.008_bib22","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1091\/mbc.e05-11-1027","article-title":"Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels","volume":"18","author":"Joch","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2008.05.008_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1152\/physrev.00007.2002","article-title":"Epithelial sodium channel\/degenerin family of ion channels: a variety of functions for a shared structure","volume":"82","author":"Kellenberger","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2008.05.008_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.05.008_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01871102","article-title":"Amiloride and its analogs as tools in the study of ion transport","volume":"105","author":"Kleyman","year":"1988","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.nbd.2008.05.008_bib26","first-page":"1077","article-title":"1H MRS identifies lactate rise in the striatum of MPTP-treated C57BL\u20446 mice","volume":"23","author":"Koga","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2008.05.008_bib27","first-page":"477","article-title":"The ASICs: signaling molecules? Modulators?","volume":"26","author":"Krishtal","year":"2003","journal-title":"TINS"},{"key":"10.1016\/j.nbd.2008.05.008_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ceca.2004.02.016","article-title":"Metabolic stages, mitochondria and calcium in hypoxic\/ischemic brain damage","volume":"36","author":"Kristian","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nbd.2008.05.008_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(04)00740-9","article-title":"Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough","volume":"3","author":"Lang","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2008.05.008_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological \u03b1-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.05.008_bib31","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1242\/jcs.03443","article-title":"A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases","volume":"120","author":"Mandemakers","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2008.05.008_bib32","first-page":"299","article-title":"Parkinson's disease as a disorder of the aging","volume":"2","author":"Martone","year":"2005","journal-title":"Drug Discov. Today: Ther. Strateg."},{"key":"10.1016\/j.nbd.2008.05.008_bib33","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.103.049445","article-title":"LY503430, a novel \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease","volume":"306","author":"Murray","year":"2003","journal-title":"JPET"},{"key":"10.1016\/j.nbd.2008.05.008_bib36","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1523\/JNEUROSCI.22-04-01290.2002","article-title":"Ih channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain","volume":"22","author":"Neuhoff","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib37","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1073\/pnas.0600768103","article-title":"Acid-sensitive ionic channels in midbrain dopamine neurons are sensitive to ammonium, which may contribute to hyperammonemia damage","volume":"103","author":"Pidoplichko","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.nbd.2008.05.008_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/brain\/awl325","article-title":"Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia","volume":"130","author":"Pignataro","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.05.008_bib39","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2008.05.008_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuron.2004.07.012","article-title":"Mitochondria and dopamine: new insights into recessive parkinsonism","volume":"43","author":"Shen","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.05.008_bib42","first-page":"209","article-title":"Acidosis-related damage","volume":"71","author":"Siesjo","year":"1996","journal-title":"Adv. Neurol."},{"issue":"suppl 1","key":"10.1016\/j.nbd.2008.05.008_bib43","first-page":"S76","article-title":"Glucose treatment preceding forebrain ischemia causes substantia nigra damage","volume":"7","author":"Smith","year":"1987","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2008.05.008_bib44","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF\u03b1","volume":"20","author":"Sririm","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2008.05.008_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2008.05.008_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.STR.24.3.435","article-title":"Brain pHi, cerebral blood flow, and NADH fluorescence during severe incomplete global ischemia in rabbits","volume":"24","author":"Tomlinson","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2008.05.008_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s004240050143","article-title":"Fast local superfusion technique","volume":"432","author":"Veselovsky","year":"1996","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.nbd.2008.05.008_bib48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0959-4388(98)80070-6","article-title":"H+-gated cation channels: neuronal acid sensors in the NaC\/DEG family of ion channels","volume":"8","author":"Waldmann","year":"1998","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2008.05.008_bib49","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1523\/JNEUROSCI.23-13-05496.2003","article-title":"Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning","volume":"23","author":"Wemmie","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib50","first-page":"578","article-title":"Acid-sensing ion channels: advances, questions and therapeutic opportunities","volume":"29","author":"Wemmie","year":"2006","journal-title":"TINS"},{"key":"10.1016\/j.nbd.2008.05.008_bib51","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.008_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2004.08.026","article-title":"Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels","volume":"118","author":"Xiong","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.05.008_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00232-005-0840-x","article-title":"Ca2+-permeable acid-sensing ion channels and ischemic brain injury","volume":"209","author":"Xiong","year":"2006","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.nbd.2008.05.008_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(02)00069-1","article-title":"Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice","volume":"322","author":"Xu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.05.008_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ceca.2004.02.013","article-title":"Calcium and pH homeostasis in neurons during hypoxia and ischemia","volume":"36","author":"Yao","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nbd.2008.05.008_bib56","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1073\/pnas.0308636100","article-title":"Extracellular acidosis increases neuronal cell calcium by activating acid-sensing ion channel 1a","volume":"101","author":"Yermolaieva","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.nbd.2008.05.008_bib57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1227\/01.NEU.0000137658.14906.E4","article-title":"Hyperglycemia and brain tissue pH after traumatic brain injury","volume":"55","author":"Zygun","year":"2004","journal-title":"Neurosurgery"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:35:15Z","timestamp":1772141715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0969996108001010"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.05.008","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiloride is neuroprotective in an MPTP model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}